Nannini Esteban C, Singh Kavindra V, Arias Cesar A, Murray Barbara E
Division of Infectious Diseases, School of Medicine, Universidad Nacional de Rosario, and Sanatorio Británico, Rosario, Argentina
Center for the Study of Emerging and Re-Emerging Pathogens, Division of Infectious Diseases, Department of Internal Medicine.
Antimicrob Agents Chemother. 2013 Sep;57(9):4276-4281. doi: 10.1128/AAC.00856-13. Epub 2013 Jun 24.
Several reports have implicated the inoculum effect that some strains of type A beta-lactamase (Bla)-producing, methicillin-susceptible (MSSA) show against cefazolin as the cause for clinical failures in certain serious deep-seated infections. Here, using a previously reported MSSA strain displaying this phenotype (TX0117), we obtained a Bla-cured derivative (TX0117c) with a combination of novobiocin and high temperature. Both isolates were then used in a rat endocarditis model and treated with cefazolin, nafcillin, and daptomycin, given to simulate human dosing. Animals were treated for 3 days and either sacrificed at 24 h after the last antibiotic dose (standard group) or left untreated for an additional 3 days (relapse group). With TX0117 in the standard treatment group, daptomycin and nafcillin were both significantly better than cefazolin in reducing CFU/g of vegetations, achieving mean log reductions compared to levels in untreated rats of 7.1, 5.3, and 1.8, respectively (cefazolin versus daptomycin, < 0.0001; cefazolin versus nafcillin, = 0.005; daptomycin versus nafcillin, = 0.053). In addition, cefazolin was significantly more effective in reducing vegetation titers of TX0117c than of TX0117 (mean log reduction of 1.4 versus 5.5, respectively; = 0.0001). Similar results were observed with animals in the relapse group. Thus, these data show that there can be an consequence of the inoculum effect that some MSSA strains display against cefazolin and indicate a specific role for Bla production using a Bla-cured derivative strain against which cefazolin regained both and activity.
几份报告表明,一些产A类β-内酰胺酶(Bla)、对甲氧西林敏感的金黄色葡萄球菌(MSSA)菌株对头孢唑林表现出的接种物效应是某些严重深部感染临床治疗失败的原因。在此,我们使用先前报道的表现出这种表型的MSSA菌株(TX0117),通过新霉素和高温联合处理获得了一株Bla缺失衍生物(TX0117c)。然后将这两种菌株用于大鼠心内膜炎模型,并给予头孢唑林、萘夫西林和达托霉素进行治疗,给药方式模拟人体剂量。动物接受治疗3天,然后在最后一剂抗生素给药后24小时处死(标准组),或者再额外3天不进行治疗(复发组)。在标准治疗组中,对于TX0117,达托霉素和萘夫西林在降低每克赘生物中的菌落形成单位(CFU)方面均显著优于头孢唑林,与未治疗大鼠相比,平均对数降低分别为7.1、5.3和1.8(头孢唑林与达托霉素比较,P<0.0001;头孢唑林与萘夫西林比较,P = 0.005;达托霉素与萘夫西林比较,P = 0.053)。此外,头孢唑林在降低TX0117c的赘生物滴度方面比TX0117更有效(平均对数降低分别为1.4和5.5;P = 0.0001)。在复发组动物中也观察到了类似结果。因此,这些数据表明,一些MSSA菌株对头孢唑林表现出的接种物效应会产生后果,并表明使用Bla缺失衍生物菌株时Bla产生具有特定作用,针对该菌株头孢唑林恢复了效力和活性。